These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8588664)

  • 1. Monitoring cochlear function intraoperatively using distortion product otoacoustic emissions.
    Telischi FF; Widick MP; Lonsbury-Martin BL; McCoy MJ
    Am J Otol; 1995 Sep; 16(5):597-608. PubMed ID: 8588664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative monitoring of cochlear function using distortion product otoacoustic emissions (DPOAEs) in patients with cerebellopontine angle tumors.
    Morawski K; Namyslowski G; Lisowska G; Bazowski P; Kwiek S; Telischi FF
    Otol Neurotol; 2004 Sep; 25(5):818-25. PubMed ID: 15354017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distortion product otoacoustic emissions and tympanometric measurements in an adult population-based study.
    Uchida Y; Ando F; Nakata S; Ueda H; Nakashima T; Niino N; Shimokata H
    Auris Nasus Larynx; 2006 Dec; 33(4):397-401. PubMed ID: 16753276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
    Dreisbach LE; Long KM; Lees SE
    Ear Hear; 2006 Oct; 27(5):466-79. PubMed ID: 16957498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of distortion product otoacoustic emissions to assess middle ear transducers in rhesus monkeys.
    Park JY; Coticchia JM; Clark WW; Esselman GH; Khosla S; Neely JG; Fredrickson JM
    Am J Otol; 1995 Sep; 16(5):576-90. PubMed ID: 8588662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortion product otoacoustic emissions in an industrial setting.
    Korres GS; Balatsouras DG; Tzagaroulakis A; Kandiloros D; Ferekidou E; Korres S
    Noise Health; 2009; 11(43):103-10. PubMed ID: 19414930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model of real time monitoring of the cochlear function during an induced local ischemia.
    Morawski K; Telischi FF; Niemczyk K
    Hear Res; 2006 Feb; 212(1-2):117-27. PubMed ID: 16403609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency distortion product otoacoustic emissions in children with and without middle ear dysfunction.
    Kei J; Brazel B; Crebbin K; Richards A; Willeston N
    Int J Pediatr Otorhinolaryngol; 2007 Jan; 71(1):125-33. PubMed ID: 17126413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive response to low-frequency cochlear distortion products in the auditory midbrain.
    Abel C; Kössl M
    J Neurophysiol; 2009 Mar; 101(3):1560-74. PubMed ID: 19036870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion-product otoacoustic emission tests evaluate cochlear function and differentiate cochlear and vestibular schwannoma.
    Kagoya R; Shinogami M; Kohno M; Yamasoba T
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):267-71. PubMed ID: 23197675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early effects of cerebellopontine angle compression on rabbit distortion-product otoacoustic emissions: a model for monitoring cochlear function during acoustic neuroma surgery.
    Widick MP; Telischi FF; Lonsbury-Martin BL; Stagner BB
    Otolaryngol Head Neck Surg; 1994 Oct; 111(4):407-16. PubMed ID: 7936673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of otoacoustic emissions following ear-level exposure to MP3 player music.
    Bhagat SP; Davis AM
    Int J Audiol; 2008 Dec; 47(12):751-60. PubMed ID: 19085399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in otoacoustic emissions and high-frequency hearing thresholds in children and adolescents.
    Groh D; Pelanova J; Jilek M; Popelar J; Kabelka Z; Syka J
    Hear Res; 2006 Feb; 212(1-2):90-8. PubMed ID: 16364580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral acoustic stimulation modulates low-frequency biasing of DPOAE: efferent influence on cochlear amplifier operating state?
    Abel C; Wittekindt A; Kössl M
    J Neurophysiol; 2009 May; 101(5):2362-71. PubMed ID: 19279155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distortion product emissions in humans. II. Relations to acoustic immittance and stimulus frequency and spontaneous otoacoustic emissions in normally hearing subjects.
    Lonsbury-Martin BL; Harris FP; Stagner BB; Hawkins MD; Martin GK
    Ann Otol Rhinol Laryngol Suppl; 1990 May; 147():15-29. PubMed ID: 2110796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of chronic otitis media with effusion on the measurement of transiently evoked otoacoustic emissions.
    Amedee RG
    Laryngoscope; 1995 Jun; 105(6):589-95. PubMed ID: 7769941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.